Efficacy and safety analysis of TACE + Donafenib + Toripalimab versus TACE + Sorafenib in the treatment of unresectable hepatocellular carcinoma: a retrospective study

OBJECTIVE: To compare the efficacy and safety of TACE combined with Donafenib and Toripalimab versus TACE combined with Sorafenib in the treatment of unresectable hepatocellular carcinoma (HCC), aiming to guide personalized treatment strategies for HCC and improve patient prognosis. MATERIALS AND ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Haohao, Liang, Bin, Xia, Xiangwen, Zheng, Chuansheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599044/
https://www.ncbi.nlm.nih.gov/pubmed/37880661
http://dx.doi.org/10.1186/s12885-023-11535-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599044/
https://www.ncbi.nlm.nih.gov/pubmed/37880661
http://dx.doi.org/10.1186/s12885-023-11535-5

Ejemplares similares